Cannabidiol as an immune modulator: A comprehensive review
Abstract Cannabidiol (CBD), a non-psychoactive phytocannabinoid derived from Cannabis sativa, has emerged as a promising therapeutic agent due to its…
Abstract Cannabidiol (CBD), a non-psychoactive phytocannabinoid derived from Cannabis sativa, has emerged as a promising therapeutic agent due to its…
Abstract Cannabis is the most commonly used illicit substance worldwide. Recent years have seen an increase in cannabis consumption, and…
Abstract Cannabidiol (CBD) is one of the major phytochemical constituents of cannabis, Cannabis sativa, widely recognized for its therapeutic potential.…
Abstract Epilepsy is the fourth most common neuropsychiatric disorder. Although the approval of Epidiolex has ignited hope for patients, there…
Abstract The poor physicochemical properties of cannabidiol (CBD) hamper its clinical development. The aim of this review was to examine…
Abstract In the last 5 years, interest has grown in using phytocannabinoids, particularly cannabidiol (CBD), in veterinary medicine to treat…
Abstract The bioavailability levels of cannabidiol (CBD) and tetrahydrocannabinol (THC) determine their pharmacological effects. Therefore, for medical purposes, it is…
Abstract The use of cannabidiol (CBD) for treating brain disorders has gained increasing interest. While the mechanism of action of…
Abstract Cannabidiol (CBD) is a non-intoxicating cannabinoid compound with diverse molecular targets and potential therapeutic effects, including effects relevant to…
Abstract The constant search for new pharmacologically active compounds, especially those that do not exhibit toxic effects, intensifies the interest…